Technical Analysis for ALT - Altimmune, Inc.

Grade Last Price % Change Price Change
grade F 1.76 2.92% 0.05
ALT closed up 2.92 percent on Wednesday, February 19, 2020, on 29 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical ALT trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 2.92%
Stochastic Buy Signal Bullish 1.15%
Oversold Stochastic Weakness 1.15%
Down 3 Days in a Row Weakness 2.92%
Down 4 Days in a Row Weakness 2.92%
Oversold Stochastic Weakness 2.92%
Stochastic Reached Oversold Weakness 2.33%
Down 3 Days in a Row Weakness 2.33%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.
Medicine Medical Specialties Vaccines Biological Warfare Manufacturing Processes Anthrax

Is ALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.94
52 Week Low 1.51
Average Volume 205,448
200-Day Moving Average 2.09
50-Day Moving Average 1.82
20-Day Moving Average 1.80
10-Day Moving Average 1.76
Average True Range 0.10
ADX 17.2
+DI 17.65
-DI 14.49
Chandelier Exit (Long, 3 ATRs ) 1.91
Chandelier Exit (Short, 3 ATRs ) 1.96
Upper Bollinger Band 1.98
Lower Bollinger Band 1.63
Percent B (%b) 0.38
BandWidth 19.27
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.006
Fundamentals Value
Market Cap 27.14 Million
Num Shares 15.4 Million
EPS -1.51
Price-to-Earnings (P/E) Ratio -1.17
Price-to-Sales 7.62
Price-to-Book 0.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.84
Resistance 3 (R3) 1.83 1.79 1.82
Resistance 2 (R2) 1.79 1.77 1.80 1.82
Resistance 1 (R1) 1.78 1.76 1.79 1.79 1.81
Pivot Point 1.74 1.74 1.75 1.75 1.74
Support 1 (S1) 1.73 1.72 1.74 1.74 1.71
Support 2 (S2) 1.69 1.71 1.70 1.70
Support 3 (S3) 1.68 1.69 1.70
Support 4 (S4) 1.69